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ABSTRACT Epithelial-mesenchymal transition (EMT) is a form of cellular plasticity that is crit-
ical for embryonic development and tumor metastasis. A double-negative feedback loop in-
volving the miR-200 family and ZEB (zinc finger E-box-binding homeobox) transcription fac-
tors has been postulated to control the balance between epithelial and mesenchymal states. 
Here we demonstrate using the epithelial Madin Darby canine kidney cell line model that, 
although manipulation of the ZEB/miR-200 balance is able to repeatedly switch cells between 
epithelial and mesenchymal states, the induction and maintenance of a stable mesenchymal 
phenotype requires the establishment of autocrine transforming growth factor-β (TGF-β) sig-
naling to drive sustained ZEB expression. Furthermore, we show that prolonged autocrine 
TGF-β signaling induced reversible DNA methylation of the miR-200 loci with corresponding 
changes in miR-200 levels. Collectively, these findings demonstrate the existence of an auto-
crine TGF-β/ZEB/miR-200 signaling network that regulates plasticity between epithelial and 
mesenchymal states. We find a strong correlation between ZEBs and TGF-β and negative cor-
relations between miR-200 and TGF-β and between miR-200 and ZEBs, in invasive ductal 
carcinomas, consistent with an autocrine TGF-β/ZEB/miR-200 signaling network being active 
in breast cancers.
INTRODUCTION
In contrast to the traditional view of cellular differentiation as being 
a unidirectional and largely irreversible process, it is now recognized 
that many differentiated cells can retain a considerable degree of 
plasticity. This capacity for plasticity is exemplified by recent remark-
able demonstrations of pluripotent stem cell (iPSC) generation from 
ostensibly fully differentiated cells through manipulation of key reg-
ulatory genes. It is also becoming apparent that formation of iPSCs 
from differentiated precursors has much in common with mesenchy-
mal-epithelial transition (MET) (Li et al., 2010; Samavarchi-Tehrani et 
al., 2010). MET and its reverse, epithelial-mesenchymal transition 
(EMT), are prime examples of reversible differentiation processes 
that occur during normal development. Indeed, some tissues in the 
developing embryo are produced as the result of up to 3 successive 
cycles of EMT and MET (Thiery et al., 2009). Such developmental 
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was shown to be targeted by miR-141/200a in cancer cells (Burk 
et al., 2008), leading to the hypothesis that repression of miR-200a 
during EMT might facilitate induction of autocrine TGF-β signaling 
(Burk et al., 2008; Gregory et al., 2008b; Ocana and Nieto, 2008). 
The importance of these interactions in the establishment and main-
tenance of EMT, however, has not yet been demonstrated. Using 
the MDCK cell model, we show that the ZEB/miR-200 double-neg-
ative feedback loop plays a central role in controlling cell plasticity 
and specifying cell phenotype. By manipulating the ZEB/miR-200 
ratio, the cell phenotype can be repeatedly switched between sta-
ble epithelial and mesenchymal states without the requirement for 
the continued influence of exogenous factors, verifying the hypoth-
esized function of the double-negative feedback model. Further-
more, we demonstrate an essential requirement for autocrine TGF-β 
signaling in both the establishment and maintenance of EMT 
through up-regulation of ZEB1 and ZEB2. Collectively, these find-
ings demonstrate that epithelial cell plasticity is controlled by an 
autocrine TGF-β/ZEB/miR-200 signaling network. Prolonged activa-
tion of this signaling network was shown to affect dynamic and re-
versible DNA methylation of the miR-200 family loci which may con-
tribute to stability of the mesenchymal state.
RESULTS
Prolonged TGF-β treatment establishes a mesenchymal 
state that is stabilized by the ZEB/miR-200 regulatory loop
On the basis of the double-negative feedback loop model, we pre-
dicted that a critical threshold in the balance between miR-200 and 
ZEB levels determines whether cells stably reside in a self-reinforc-
ing epithelial or mesenchymal state. As a consequence, cells that 
are induced to undergo a change in state (e.g., induced by TGF-β to 
undergo EMT) should remain in that state indefinitely, without the 
need for ongoing stimulation with the inducer. To test this proposi-
tion we induced EMT in MDCK cells with TGF-β1 and then removed 
it at varying time points while monitoring cell morphology, miR-200, 
and ZEB1 and ZEB2 expression. After 2 d of TGF-β1 treatment, the 
epithelial cells began to adopt a mesenchymal morphology, but at 
this stage only the miR-200b∼200a∼429 cluster (represented by 
miR-200b) was repressed, and ZEB1 and ZEB2 proteins were not yet 
detectable (Figure 1, A–C). After 5 d of treatment, both miR-200 
clusters were repressed (miR-200c∼141 by ∼50%; represented by 
miR-200c), and this result was coincident with greatly elevated levels 
of ZEB1 mRNA and protein. When TGF-β1 was removed at this time 
point, the cells reverted back to an epithelial morphology and ex-
pression profile (Figure 1, A–C), suggesting that the changes in miR-
200 and ZEB levels had not reached a critical threshold to maintain 
the mesenchymal state. By 8 d of TGF-β1 treatment, the microRNAs 
from both miR-200 clusters were strongly repressed, coincident with 
a large up-regulation of both ZEB1 and ZEB2 proteins. Of note, the 
change in ZEB1 and ZEB2 mRNA between days 5 and 8 was rela-
tively small in comparison to protein level changes, suggesting that 
the protein elevation was caused by a loss of miR-200–mediated 
translational repression. Removal of TGF-β1 after 8 d of treatment 
resulted in the cells maintaining a mesenchymal morphology and 
expression profile which was stable for several months in culture 
(hereafter called MDCK-TGF cells) (Figure 1, A–C). In these stable 
mesenchymal cells, ZEB2 expression continued to increase whereas 
ZEB1 expression decreased from its day 8 levels, suggesting that 
ZEB2 function may be more important in this context. These results 
are consistent with the prediction that a crucial threshold in the ZEB/
miR-200 balance sets the cell phenotype.
To determine whether the stable mesenchymal state of 
MDCK-TGF cells retained plasticity, we directly manipulated the 
plasticity requires that cells be capable of maintaining a stable dif-
ferentiated phenotype yet retain the capacity to switch to an alter-
native phenotype. EMT has also been extensively demonstrated to 
enhance the invasive properties of epithelial tumor cells and pro-
mote tumor metastasis (Thiery, 2002; Berx et al., 2007). Recent stud-
ies have shown that this process is also associated with the acquisi-
tion of tumor initiating and self-renewal properties (Mani et al., 2008) 
with interconversions between epithelial and mesenchymal states 
being postulated to influence tumor malignancy (Gupta et al., 2009; 
Polyak and Weinberg, 2009). Therefore, deciphering the pathways 
controlling epithelial cell plasticity has broad implications for our 
understanding of developmental processes and may represent im-
portant therapeutic targets for cellular reprogramming and tumori-
genesis.
Among several growth factors that can act as inducers of EMT, 
transforming growth factor-β (TGF-β) has been found to play an im-
portant role in particular stages of development and in disease pro-
cesses, such as fibrosis and cancer metastasis (Zeisberg and Kalluri, 
2004; Derynck and Akhurst, 2007; Pardali and Moustakas, 2007). 
TGF-β induces the transcription factors Snail, Slug, zinc finger E-
box-binding homeobox (ZEB)1, and ZEB2 (also known as SIP1), 
which are each implicated in mediating the effects of TGF-β at least 
in part through repression of E-cadherin and initiation of EMT 
(Peinado et al., 2007). The Madin Darby canine kidney (MDCK) cell 
line has been used extensively as an in vitro model of EMT. In cul-
ture, these cells have all the hallmarks of epithelial cells, but convert 
to mesenchymal cells in response to TGF-β. We previously used 
these cells to identify microRNAs that are involved in specifying 
epithelial phenotype and to identify a double-negative regulatory 
feedback loop involving microRNAs of the miR-200 family and the 
transcription repressors ZEB1 and ZEB2 (collectively ZEB) (Bracken 
et al., 2008; Gregory et al., 2008a). In this feedback loop, the miR-
200 family repress ZEBs, and ZEBs, which are expressed in mesen-
chymal cells, repress the transcription of the two gene loci (miR-
200b∼200a∼429 and miR-200c∼141) encoding the five members of 
the miR-200 family (Bracken et al., 2008; Burk et al., 2008). Both 
miR-200 and ZEBs have independently been found to participate in 
the control of EMT in many different cell types and can mediate the 
effects of TGF-β signaling (Comijn et al., 2001; Postigo et al., 2003; 
Eger et al., 2005; Hurteau et al., 2007; Shirakihara et al., 2007; Burk 
et al., 2008; Korpal et al., 2008; Park et al., 2008).
The ZEB/miR-200 double-negative feedback loop has been pos-
tulated to explain both the stability and interchangeability of the 
epithelial versus mesenchymal phenotypes (Gregory et al., 2008b; 
Brabletz and Brabletz, 2010), but to date this has not been tested 
within a single cell system. In this proposed model, the miR-200 
family predominates in epithelial cells and prevents expression of 
ZEB1 and ZEB2, allowing E-cadherin and other epithelial genes to 
be fully expressed, whereas in mesenchymal cells the ZEB factors 
prevent expression of miR-200, E-cadherin, and other epithelial 
genes. The ZEB/miR-200 feedback loop predicts that a perturbing 
influence such as TGF-β would need to change the balance be-
tween miR-200 and ZEB factors beyond a threshold, which would 
then be self-reinforcing and reset the state of the cells in the alterna-
tive phenotype. This new cell state would be metastable but able to 
be reversed if the balance of miR-200 and ZEB was altered by up-
stream changes in cell signaling.
In a number of EMT model systems it has been shown that auto-
crine TGF-β signaling contributes to the stability of the mesenchy-
mal state in conjunction with oncogenic Ras, Raf, or Fos overexpres-
sion (Oft et al., 1996; Lehmann et al., 2000; Janda et al., 2002; Eger 
et al., 2004). Recently, one of the TGF-β family members, TGF-β2, 
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ZEB/miR-200 balance by transfection of 
ZEB1 and ZEB2 siRNAs or miR-200a and 
miR-200b pre-miRs into these cells. Increas-
ing the miR-200 levels or reducing ZEB lev-
els restored these mesenchymal cells back 
to an epithelial morphology and expression 
profile (Figure 1, D and E). Furthermore, 
when we added TGF-β1 back to the epithe-
lially reverted cells they were able to un-
dergo yet another EMT (Figure 1D). These 
results show that the epithelial and mesen-
chymal phenotypes can be consecutively 
switched in either direction in response to 
manipulation of the ZEB/miR-200 balance.
Autocrine TGF-β signaling is required 
for the maintenance of the 
mesenchymal state of MDCK-TGF cells
In the stable mesenchymal state, decreased 
miR-200 levels would allow for uninhibited 
production of ZEB proteins, but we rea-
soned that sustained ZEB transcription 
would also be needed to maintain high lev-
els of ZEB mRNAs. Because it has been 
well documented in studies with MDCK 
and other EMT cell culture models that 
TGF-β can cooperate with other signaling 
pathways initiated by factors including Ras, 
Raf, and Fos to establish autocrine TGF-β 
signaling (Oft et al., 1996; Lehmann et al., 
2000; Janda et al., 2002; Eger et al., 2004; 
Medici et al., 2008), we considered that 
prolonged TGF-β treatment might initiate 
autocrine TGF-β signaling to promote the 
ZEB transcription that enforces the stable 
mesenchymal state of the MDCK-TGF cells. 
To test this possibility, we first measured 
the expression of endogenous TGF-β1, 
FIGURE 1: Prolonged TGF-β treatment establishes a mesenchymal state that is stabilized by the 
ZEB/miR-200 regulatory loop. (A) Cell morphology of MDCK cells treated with TGF-β1 over an 
8-d time course as indicated, followed by its 
removal. MDCK-TGF designates MDCK cells 
that remain mesenchymal 35 d after 
cessation of the TGF-β1 treatment. “Epith 
rev” designates MDCK cells which had been 
treated with TGF-β1 for 5 d followed by 
TGF-β1 withdrawal for 12 d, resulting in 
reversion back to an epithelial phenotype. 
(B) Western blot and (C) real-time PCR of 
EMT markers and miR-200 family members 
over the TGF-β1 time course. (D) Cell 
morphology of MDCK-TGF transfected with 
ZEB1 and ZEB2 siRNAs or miR-200a and 
miR-200b pre-miRs (representing both 
“seed” sequence groupings, miR-
200b/200c/429 and miR-141/200a, within the 
miR-200 family) or their negative controls 
over a 6-d period followed by treatment with 
TGF-β1 for 6 d. (E) Real-time PCR of EMT 
markers after miR-200 transfection or ZEB 
knockdown as shown in (D). Data are 
representative of triplicate experiments. Each 
value shown is the mean ± SD of three 
replicate measurements.
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with an inhibitor of TGF-β receptor 1 (RI) activity, SB-505124. Addi-
tion of this inhibitor led to a time-dependent decrease in ZEB 
mRNA (Figure 2C), consistent with autocrine TGF-β produced by 
MDCK-TGF cells being required for ZEB transcription in these 
cells. Concomitant with the loss of ZEB was an increase in miR-200 
expression (see Figure 6C later in the paper and Supplemental 
Figure 3C), accompanied by hallmark epithelial features, such as 
expression of E-cadherin and ZO-1 on the plasma membrane, and 
a rearrangement of F-actin in a cortical pattern (Figure 2D). Similar 
effects were also observed with a different TGF-β RI inhibitor, SB-
431542, confirming that the epithelial reversion was caused by 
TGF-β pathway inhibition (Supplemental Figure 1A).
To confirm whether secreted TGF-β mediates autocrine TGF-β 
signaling in MDCK-TGF cells, we added anti-TGF-β antibodies to 
the culture medium. Addition of a pan TGF-β1/2/3 antibody to 
the culture medium caused a time-dependent increase in miR-200 
levels and drove the cells toward an epithelial phenotype (Figure 
2, D and E). These changes were not observed with the individual 
TGF-β1, -β2, or -β3 neutralizing antibodies, suggesting that there 
is redundancy in the function of these ligands in this cell system 
(Figure 2E). The redundant function of these ligands is further 
supported by the ability of TGF-β2 and TGF-β3 to each induce 
EMT in MDCK cells (Supplemental Figure 1B). Collectively, these 
data demonstrate that autocrine TGF-β signaling, involving induc-
tion and secretion of TGF-β1, -β2, and -β3, is required for stabili-
zation of the mesenchymal phenotype of MDCK-TGF cells and 
that this is not dependent on the presence of other exogenous 
factors.
Autocrine TGF-β signaling maintains the stable 
mesenchymal state through up-regulation of ZEB1 
and ZEB2
The findings reported in the preceding section suggest that au-
tocrine TGF-β signaling maintains the stable mesenchymal state 
of MDCK-TGF cells through up-regulation of ZEB1 and ZEB2. To 
further test this possibility, we assessed whether ZEB expression 
can obviate the requirement for autocrine TGF-β signaling in 
maintaining the mesenchymal state by inhibiting TGF-β signaling 
in cells where ZEB1 or ZEB2 expression has been stably enforced 
(Bracken et al., 2008). At the same time, we tested whether the 
EMT-inducing transcription factor Snail could perform a similar 
function to ZEB by generating MDCK cell lines with constitutive 
Snail expression. MDCK-TGF cells were used as a control for this 
experiment. Individual clones from the MDCK-ZEB1, ZEB2, and 
Snail cell lines displayed a mesenchymal phenotype as expected, 
accompanied by an increase in TGF-β1, -β2, and -β3 levels rela-
tive to empty vector (EV) clones (Figure 3A). Addition of the 
TGF-β RI inhibitor, SB-505124, caused MDCK-TGF and MDCK-
Snail cells to revert to an epithelial phenotype over time with in-
creased levels of miR-200 expression (Figure 3, B and C). In con-
trast, the MDCK-ZEB1 and MDCK-ZEB2 cells were resistant to 
the effects of TGF-β inhibition, with miR-200 levels remaining re-
pressed and the cells maintaining a mesenchymal morphology 
after 25 d of treatment (Figure 3, B and C). Removal of the TGF-β 
inhibitor after this time point allowed MDCK-Snail cells to transi-
tion back to a mesenchymal morphology with decreased miR-
200 levels after 13 d, whereas the MDCK-TGF cells remained 
stably epithelial and maintained miR-200 expression for several 
months in culture (44-d time point shown; Figure 3, B and C). 
These data demonstrate that enforced ZEB1 or ZEB2, but not 
Snail, expression is sufficient to prevent the mesenchymal cells 
from increasing miR-200 expression and undergoing MET in 
TGF-β2, and TGF-β3 mRNAs and found that they were progres-
sively induced by TGF-β1 treatment and that TGF-β1 and TGF-β2 
proteins were secreted by MDCK-TGF cells (an assay for TGF-β3 
protein was not available) (Figure 2, A and B). To determine 
whether response to this endogenously synthesized TGF-β is im-
portant for mesenchymal stability, we treated MDCK-TGF cells 
FIGURE 2: Autocrine TGF-β signaling is required for the maintenance 
of a mesenchymal state. (A) Real-time PCR measurements of TGF-β 
family members after exogenous TGF-β1 treatment of MDCK cells. 
TGF-β3 levels were not detected (N.D.) in untreated MDCK cells. Data 
are normalized to untreated levels for TGF-β1 and TGF-β2 or Day 2 
levels for TGF-β3. (B) TGF-β1 and TGF-β2 secreted by MDCK and 
MDCK-TGF cells into the culture medium was measured by ELISA. 
A TGF-β3 ELISA was not available for measurement of secreted 
TGF-β3. (C) Real-time PCR measurement of ZEBs in MDCK-TGF cells 
after inhibition of TGF-β signaling using the TGF-βRI inhibitor (1 μM 
SB-505124; 13 d) (D) Immunofluorescence staining of E-cadherin (red) 
and ZO-1 (green), and rhodamine phalloidin staining of F-actin in 
MDCK-TGF cells either untreated or treated with a TGF-βRI inhibitor 
[as in (C)] or a TGF-β1/2/3 neutralizing antibody (100 μg/ml; 15 d). 
Cells are counterstained with DAPI to visualize nuclei. Scale bars = 
50 μm. (E) Quantitation of miR-200 levels in MDCK-TGF cells treated 
with individual TGF-β1, -β2, -β3 and -β1/2/3 neutralizing antibodies 
(100 μg/ml) after 7 or 15 d of treatment. Values are the mean ± SD of 
three replicate measurements.
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the ZEB/miR-200 balance. Collectively, these data support the 
notion that autocrine TGF-β signaling acts to maintain the mes-
enchymal state through up-regulation of ZEB1 and ZEB2 and re-
pression of miR-200.
response to TGF-β pathway inhibition. Although enforced Snail 
expression cannot counteract the effects of TGF-β pathway inhi-
bition, it is able to drive cells back into EMT when this inhibition 
is removed, suggesting that Snail expression is able to influence 
FIGURE 3: Ectopic expression of ZEB1 or ZEB2 abrogates MET following inhibition of autocrine TGF-β signaling. 
(A) Real-time PCR measurements of TGF-β family members in two individual EV, MDCK-ZEB1, MDCK-ZEB2, and 
MDCK-Snail clones. (B) Phase contrast micrographs of MDCK-stable cells before and after treatment with 1 μM 
SB-505124 (25 d) and 13 d after removal of the inhibitor. (C) Real-time PCR measurements of miR-200b and miR-200c in 
MDCK-stable cells treated as in (B). The measurement for the MDCK-TGF cells was taken at day 44 after removal of the 
TGF-βRI inhibitor showing the stability of the reverted epithelial state.
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Autocrine TGF-β signaling is required for ZEB up-regulation 
during EMT induction
As shown earlier in the text and in previous studies, inhibition of 
miR-200 is able to initiate an EMT of MDCK cells, and this initiation 
of EMT is dependent on up-regulation of ZEB (Gregory et al., 
2008a). In the studies described here, we have found that autocrine 
TGF-β signaling is required to maintain the mesenchymal state 
through up-regulating ZEB levels. To determine whether autocrine 
TGF-β signaling is also required for ZEB up-regulation during the 
induction of EMT, we treated MDCK cells with the SB-505124 TGF-β 
RI inhibitor while repressing the miR-200 family. Blockade of TGF-β 
signaling largely prevented the ability of the miR-200 anti-miR to 
up-regulate ZEB mRNA (Figure 5A) and to transition MDCK cells 
toward a mesenchymal phenotype, as shown by maintenance of E-
cadherin and ZO-1 expression on the plasma membrane (Figure 
5B). To verify that miR-200 was effectively inhibited by the anti-miR 
in the cells treated with SB-505124, we checked whether derepres-
sion of an unrelated target, CFL2 (Burk et al., 2008), occurred in the 
presence of SB-505124. Unlike ZEB, CFL2 was derepressed by the 
miR-200 anti-miR equally well in the presence or absence of the 
TGF-β signaling inhibitor (Figure 5A), demonstrating that autocrine 
TGF-β signaling is specifically required for ZEB up-regulation, even in 
the absence of miR-200 functional activity. Furthermore, these data 
show that, in the absence of TGF-β signaling, cells can remain in an 
epithelial state despite the lack of miR-200 activity.
TGF-β is known to signal through phosphorylation-mediated ac-
tivation of Sma and Mad related family (Smad) transcription factors 
and in some cases by activation of the phosphoinositide 3-kinase 
and extracellular-signal regulated kinase/mitogen-activated protein 
kinase (ERK/MAPK) pathways to induce EMT (Miyazono, 2009). 
Smads have been previously shown to interact with the ZEB2 pro-
moter and activate its transcription in MCF10A cells (Lu et al., 2009), 
suggesting that Smad signaling might be important for ZEB up-
regulation during EMT. To investigate this possibility, we treated 
MDCK cells with TGF-β1 in the presence of an siRNA toward the 
Smad2/3 binding partner Smad4. Smad4 knockdown almost com-
pletely suppressed up-regulation of ZEB1 and ZEB2 mRNA and pre-
vented induction of EMT (Figure 5, C and D). These data indicate 
that autocrine TGF-β signaling through the Smad pathway is re-
quired for ZEB up-regulation during the induction of EMT. Collec-
tively, our findings demonstrate that the induction and maintenance 
of EMT is integrally controlled by a tripartite autocrine TGF-β/ZEB/
miR-200 signaling network, with the balance of each factor deter-
mining the outcome of epithelial or mesenchymal cell phenotype.
Prolonged autocrine TGF-β signaling promotes reversible 
DNA methylation of the miR-200 family promoters
Although we have shown an important role for the autocrine TGF-β/
ZEB/miR-200 network in maintaining the mesenchymal stability of 
MDCK-TGF cells, it is possible that epigenetic changes may be rein-
forcing this state. Recent reports have implicated a role for sustained 
TGF-β signaling in the DNA hypermethylation of E-cadherin and 
other genes silenced in basal-like breast cancers (Dumont et al., 
2008; Papageorgis et al., 2010). In independent studies, the miR-200 
loci have been shown to be subject to epigenetic repression through 
hypermethylation in gastric and breast cancer cell lines (Neves 
et al., 2010; Vrba et al., 2010; Wiklund et al., 2011). We hypothe-
sized that prolonged exposure to TGF-β may lead to DNA hyperm-
ethylation of the miR-200 promoters and long-term suppression of 
its expression. To test this hypothesis, we first examined CpG meth-
ylation of the miR-200b∼200a∼429 proximal promoter in cells treated 
with TGF-β1 for 26 d and in MDCK-Pez cells which have been stably 
Manipulation of miR-200 and ZEB levels influences 
TGF-β production
It has recently been shown that TGF-β2 is directly targeted by 
miR-141/200a in breast and colon cancer cell lines (Burk et al., 
2008), suggesting that the loss of miR-200 family members dur-
ing EMT might enhance autocrine TGF-β signaling through re-
moval of this repression of TGF-β2. TGF-β1 and TGF-β3 are not 
predicted to be direct targets of miR-200 but may be influenced 
indirectly by the ZEB/miR-200 loop. We therefore investigated 
the extent to which the ZEB/miR-200 feedback loop impacts 
TGF-β production in epithelial and mesenchymal cells by directly 
manipulating their levels. First, we measured TGF-β mRNA levels 
in MDCK-TGF cells following ectopic expression of miR-200a 
and miR-200b or knockdown of ZEB1 and ZEB2 as shown in Fig-
ure 1. Both of these treatments decreased each of the TGF-β 
mRNAs, with the strongest effect being on TGF-β3 (Figure 4A). 
Next, we inhibited endogenous miR-200 expression in MDCK 
cells using a locked nucleic acid (LNA) anti-miR designed to bind 
all members of the miR-200 family. Knockdown of miR-200 family 
caused an increase in each of the TGF-β mRNAs, with the stron-
gest effect being on TGF-β3 (Figure 4B). These changes occur 
concomitantly with increases in ZEB mRNA levels but before al-
terations in cell morphology and E-cadherin expression (Supple-
mental Figure 2), suggesting that autocrine TGF-β induction by 
miR-200 repression precedes acquisition of a mesenchymal phe-
notype. Taken together, these data indicate that manipulation of 
miR-200 and ZEB levels influences the expression of all three 
TGF-β isoforms, most likely by direct and indirect mechanisms 
given the lack of putative miR-200 target sites in TGF-β1 and 
TGF-β3.
FIGURE 4: The ZEB/miR-200 regulatory loop regulates TGF-β 
production. (A) Real-time PCR measurement of TGF-β isoform levels 
following transfection of MDCK-TGF cells with ZEB1 and ZEB2 
siRNAs or miR-200a and miR-200b pre-miRs relative to their negative 
controls for 6 d. (B) Measurement of TGF-β isoforms after transfection 
of MDCK cells with a control or LNA miR-200 family Anti-miR (10 d). 
Data are representative of duplicate experiments. Each value shown is 
the mean ± SD of three replicate measurements.
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lation across these regions was more pro-
nounced in MDCK-Pez cells, suggesting that 
prolonged TGF-β exposure may enhance 
this process. We next examined CpG meth-
ylation of the miR-200b and miR-200c pro-
moters over an extended TGF-β1 time 
course using PCR melt curve analysis (Sup-
plemental Figure 3A). The DNA methylation 
of both miR-200 loci progressively increased 
with the duration of TGF-β exposure (by ei-
ther exogenous or autocrine TGF-β); this in-
crease was accompanied by a progressive 
decrease in miR-200 expression, consistent 
with a role for de novo DNA methylation in 
repressing miR-200 expression (Figure 6B 
and Supplemental Figure 3B).
To determine whether sustained TGF-β 
signaling was required for maintenance of 
miR-200 promoter methylation, we mea-
sured DNA methylation in MDCK-TGF cells 
treated with the TGF-β RI inhibitor SB-
505124. In accordance with the progressive 
increase in miR-200 levels, the DNA methy-
lation across both miR-200 promoters pro-
gressively decreased to a level at which little 
or none was detected at 24 d (Figure 6C 
and Supplemental Figure 3C). Collectively, 
these data demonstrate that prolonged au-
tocrine TGF-β signaling promotes de novo 
CpG methylation of the miR-200 loci which 
is reversible upon inhibition of TGF-β signal-
ing. In accordance with previous reports 
(Neves et al., 2010; Vrba et al., 2010) we 
also observed DNA hypermethylation of 
both miR-200 promoters in mesenchymal 
breast cancer cell lines in which miR-200 is 
repressed, but not in epithelial breast 
cancer cell lines with high miR-200 levels 
(Figure 6D) (Gregory et al., 2008a). This find-
ing suggests that DNA hypermethylation of 
the miR-200 promoters may be an impor-
tant mechanism for maintaining prolonged 
miR-200 repression during breast cancer 
progression.
Invasive ductal breast carcinomas 
display evidence of an operative 
autocrine TGF-β/ZEB/miR-200 
signaling network
The TGF-β pathway plays a complex role in 
tumor progression, acting as a tumor sup-
pressor in early-stage carcinoma but stimu-
lating tumor cell migration and EMT in ad-
vanced cancer (Bierie and Moses, 2006). 
Recent gene-profiling studies have identi-
fied TGF-β–responsive signatures that cor-
relate with breast cancer metastasis, rein-
forcing the role of this pathway as a potent driver of breast cancer 
progression (Padua et al., 2008). Considering the interconnection 
between TGF-β signaling and the ZEB/miR-200 regulatory loop, 
we examined invasive ductal carcinomas (IDCs) for evidence of this 
signaling network in invasive breast cancers. Real-time PCR was 
mesenchymal for 12 mo as a result of autocrine TGF-β production 
due to overexpression of the tyrosine phosphatase Pez (Wyatt et al., 
2007). Sequencing of bisulfite-modified DNA showed that TGF-β 
induced de novo CpG methylation of several promoter regions that 
were unmethylated in parental MDCK cells (Figure 6A). DNA methy-
FIGURE 5: Autocrine TGF-β signaling is required for EMT induction by the ZEB/miR-200 
regulatory loop. (A) Quantitation of ZEB1, ZEB2, and CFL2 levels in MDCK cells transfected with 
a control (neg) or LNA miR-200 family Anti-miR in the absence or presence of a TGF-β RI 
inhibitor (1 μM SB-505124; 14 d). Data are representative of duplicate experiments. Each value 
shown is the mean ± SD of three replicate measurements. (B) Merged images showing 
E-cadherin (red), ZO-1 (green), and nuclei (blue) staining of the cells. Scale bars = 100 μm. 
(C) Phase contrast micrographs of MDCK cells after transfection with control (neg) or Smad4 
siRNAs followed by TGF-β1 treatment for 3 d. (D) Real-time PCR of Smad4 and EMT markers in 
cells described in (C). Data are representative of duplicate experiments. Each value shown is the 
mean ± SD of three replicate measurements.
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miR-200b∼200a∼429 cluster and the TGF-βs or ZEB, or with any of 
the miR-200 family and TGF-β3 (Supplemental Table 1). Collectively, 
these data support a potential role for an autocrine TGF-β/ZEB/miR-
200 signaling network in invasive breast cancers and indicate that 
there may be some specificity of interaction among miR-200, ZEB, 
and TGF-β family members in breast cancer cells.
DISCUSSION
In this study, we demonstrate that epithelial cell plasticity is regu-
lated by a tripartite autocrine TGF-β/ZEB/miR-200 signaling network 
which provides a mechanistic explanation for the stable and yet 
performed using RNA obtained from regions of 27 high grade 
IDCs that were histologically defined to contain primarily tumor 
cells. Comparing miR-200c∼141 cluster expression with TGF-β1, 
TGF-β2, ZEB1, and ZEB2, we found highly significant inverse correla-
tions (p < 0.01) for each pairwise comparison, the only exception 
being that miR-141 and TGF-β1 levels were not significantly corre-
lated (Figure 7 and Supplemental Table 1). Strong direct correlations 
were also observed among all three TGF-β isoforms and ZEB1 and 
ZEB2 (p < 0.002), consistent with a role for autocrine TGF-β signal-
ing in activating ZEB transcription (Figure 7 and Supplemental Table 
1). Interestingly, we did not find significant correlations involving the 
FIGURE 6: Prolonged autocrine TGF-β signaling promotes reversible DNA methylation of the miR-200 family 
promoters. (A) Mapping of methylated CpGs across a ∼2.5 kb region spanning the miR-200b∼200a∼429 cluster 
transcription start site. Several clones were sequenced from bisulfite-modified genomic DNA derived from MDCK, 
MDCK cells treated with TGF-β1 for 26 d, and MDCK cells stably expressing the tyrosine phosphatase Pez (possessing 
autocrine TGF-β signaling). Black and white circles indicate methylated and unmethylated CpGs, respectively. (B) PCR 
melt curve analysis of the CpG-rich region encompassing the miR-200c∼141 transcription start site (see Supplemental 
Figure 3A). MDCK cells were treated with TGF-β1 for the indicated time periods followed by melt curve analysis with 
MDCK and MDCK-Pez samples representing unmethylated and methylated baseline profiles. MDCK-TGF (d164) are 
cells treated with TGF-β1 for 8 d followed by its removal for 156 d. (C) TGF-β signaling was inhibited in methylated 
stable mesenchymal cells (MDCK-TGF d164) using the 1 μM SB-505124 over a 24-d time course and methylation of the 
miR-200c∼141 promoter assessed by melt curve analysis. For (C) and (D), miR-200c levels were measured in these 
samples, or samples at similar time points, by real-time PCR. Data are representative of duplicate experiments. Each 
value shown is the mean ± SD of three replicate measurements. (D) Methylation of the miR-200b∼200a∼429 and 
miR-200c∼141 proximal promoters in epithelial (high miR-200) or mesenchymal (low miR-200) human breast cancer cell 
lines (characterized for miR-200 expression in Gregory et al., 2008a). The degree of methylation was assessed by melt 
curve analysis and scored as follows: A melt curve that approached the unmethylated control was scored –, a melt curve 
that approached the methylated control was scored as ++, and a plot that was between the unmethylated and 
methylated controls was scored as +. MCF-7 cells were shown to have both unmethylated and methylated alleles by 
cloning of PCR products, which could reflect allelic specific methylation.
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loop and was necessary for the induction and maintenance of ZEB 
expression in the mesenchymal state. These findings demonstrate 
that a tripartite autocrine TGF-β/ZEB/miR-200 signaling network 
controls both the establishment and maintenance of EMT.
The mechanisms through which the ZEB/miR-200 feedback loop 
regulates and is controlled by autocrine TGF-β is not yet fully eluci-
dated but is likely to involve both direct and indirect interactions. In 
accordance with previous observations that Smads interact with the 
ZEB2 promoter (Lu et al., 2009), we observed that knockdown of 
Smad4 prevented up-regulation of ZEB mRNAs and induction of 
EMT. Autocrine TGF-β was also shown to be required for the main-
tenance of the mesenchymal state of MDCK-TGF cells as inhibition 
of this signaling pathway resulted in cells reverting to an epithelial 
phenotype. By ectopically expressing either ZEB or Snail in MDCK 
cells, we provide evidence that autocrine TGF-β signaling acts 
through up-regulation of ZEB1 and ZEB2, but not Snail, to repress 
miR-200 and enforce the mesenchymal phenotype. These observa-
tions indicate that a specific interaction of autocrine TGF-β signaling 
with ZEB is needed for stability of the mesenchymal state. The fact 
that ectopically expressed Snail did not repress miR-200 expression 
when TGF-β signaling was blocked indicates that Snail does not di-
rectly repress miR-200, but acts indirectly through stimulating auto-
crine TGF-β. Snail has been shown to be essential for the initial in-
duction of ZEB1 in NMuMG cells (Dave et al., 2011), suggesting that 
Snail is an essential early mediator of activation of the TGF-β/ZEB/
miR-200 pathway. Conversely, we also demonstrated that direct ma-
nipulation of miR-200 or ZEB levels could influence expression of 
TGF-β1, TGF-β2, and TGF-β3. Previous studies have shown that 
miR-141/200a can directly target TGF-β2 (Burk et al., 2008; Wang 
et al., 2011), leading to the proposal that low miR-200 levels may 
promote autocrine TGF-β signaling (Burk et al., 2008; Gregory et al., 
2008a). We observed, however, that TGF-β3 experienced the 
largest change in its levels after miR-200 manipulation. Considering 
that TGF-β1 and TGF-β3 are not predicted to be direct targets of 
the miR-200 family, it is likely that changes in TGF-β expression by 
miR-200 in MDCK cells are caused by a combination of direct and 
indirect effects. Although individual TGF-β isoforms are known to 
have context-specific functions (Romano and Runyan, 2000; 
Nawshad et al., 2007), we observed a redundancy in the function 
of the TGF-β isoforms in maintaining the mesenchymal state of 
MDCK-TGF cells. Given that TGF-β isoforms are also known to reg-
ulate the expression of one another in MDCK cells (Medici et al., 
2008), it is likely that the interactions between the ZEB/miR-200 
loop and autocrine TGF-β signaling are complex. Interestingly, sev-
eral other components within the TGF-β signaling pathway (includ-
ing Smad2 and TGF-βRI) have recently been shown to be targeted 
by the miR-200 family in anaplastic thyroid carcinomas (Braun et al., 
2010), and these interactions may also be relevant in promoting au-
tocrine TGF-β signaling and epithelial cell plasticity in this and other 
contexts.
Although we have shown that the autocrine TGF-β/ZEB/miR-200 
signaling network is central to the initiation and maintenance of EMT 
in MDCK cells, a number of other EMT-inducing transcription factors 
may also have functions within this context. This is particularly evi-
dent at the early stages of TGF-β1–induced EMT in MDCK cells 
where the transcription factors Snail and Slug have been shown to be 
rapidly induced within 24 h of treatment (Peinado et al., 2003; Medici 
et al., 2006; Morita et al., 2007). We found that ZEB1 and ZEB2 mR-
NAs are induced within 2 d of TGF-β treatment but that their protein 
levels remain undetectable for several more days. This finding is con-
sistent with the high levels of miR-200 acting to repress translation of 
these mRNAs and suggests that factors other than the ZEB/miR-200 
reversible nature of EMT observed in many developmental and 
pathological scenarios. In response to TGF-β stimulation, MDCK 
cells transition toward a mesenchymal state which is stabilized only 
after 5–8 d of exogenous TGF-β1 exposure. This finding indicates 
that threshold changes in the level of ZEB, miR-200, and TGF-β are 
important in determining the final outcome of cell state. These find-
ings are consistent with the proposed function of the ZEB/miR-200 
double-negative feedback loop model in which self-reinforcing, op-
posing expression of miR-200 and ZEB develops over time and 
eventually leads to a stable change in cell state (Gregory et al., 
2008b; Brabletz and Brabletz, 2010). This model also predicts that 
the endpoint state would remain stable and be buffered against 
subthreshold changes in miR-200 and ZEB. In support of this con-
cept, we observed that short-term TGF-β1 treatment (<5–8 d) in-
duces only a transient EMT which was reversible upon factor with-
drawal. These data are also consistent with the hypothesis that the 
epithelial phenotype is the default state in the absence of factors 
that induce transition toward a mesenchymal state (Frisch, 1997; 
Polyak and Weinberg, 2009). To confirm the importance of the ZEB/
miR-200 feedback loop in determining cell state, we altered the bal-
ance of these factors either directly or indirectly (with TGF-β) and 
showed that we could repeatedly switch cells between epithelial 
and mesenchymal states. Integral to this process, however, was the 
influence of these factors on autocrine TGF-β signaling. Autocrine 
TGF-β signaling was initiated and regulated by the ZEB/miR-200 
FIGURE 7: Invasive ductal breast carcinomas display evidence of an 
operative autocrine TGF-β/ZEB/miR-200 signaling network. Real-time 
PCR was performed using total RNA isolated from 27 invasive ductal 
breast cancer samples and the expression of miR-200c, ZEB1, ZEB2, 
TGF-β1, and TGF-β2 was compared in a pairwise manner. The line of 
best fit was obtained by linear regression analysis with 95% 
confidence intervals shown. p values were calculated using Pearson 
correlation coefficients.
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histone demethylase complex (Wang et al., 2009), of which ZEB1 is 
a component that facilitates complex recruitment to ZEB binding 
sites (Wang et al., 2007), providing a potential connection between 
ZEB and miR-200 gene methylation. In addition to the MDCK EMT 
model, we found that invasive mesenchymal breast cancer cell lines 
also exhibit methylated miR-200 promoters, in contrast to epithelial 
cells in which the miR-200 promoters were unmethylated. Similar 
findings have recently been observed in primary mesenchymal 
breast cells and invasive bladder tumors (Vrba et al., 2010; Wiklund 
et al., 2011). Taken together, these data suggest that DNA methyla-
tion of the miR-200 promoters contributes to their silencing during 
EMT and cancer progression.
TGF-β expression is often increased in tumor cells and can act in 
an autocrine and paracrine manner within the tumor microenviron-
ment to enhance cancer progression (Bierie and Moses, 2006). Our 
data suggest that the autocrine TGF-β/ZEB/miR-200 signaling axis 
may be involved in mediating progression of breast cancer. This find-
ing is supported by a recent study in which a TGF-β–responsive sig-
nature, including elevated ZEB1 levels, was found to be an indepen-
dent predictor of breast cancer metastasis to the lung (Padua et al., 
2008). Knockdown of ZEB1 in cancer cell lines has been shown to 
reduce both tumor size and metastases in xenograft mouse models, 
verifying its ability to enhance tumor progression (Spaderna et al., 
2008; Wellner et al., 2009). Several reports have shown that enforced 
miR-200 expression correlates with reduced ZEB expression and inva-
sive potential in a range of cancer cell lines (Burk et al., 2008; Gibbons 
et al., 2009; Kong et al., 2009). We found that increased expression 
of TGF-β1 and TGF-β2 correlated with low miR-200c and high ZEB 
expression in invasive ductal breast cancer samples. Interestingly, 
these correlations were not observed generally with all TGF-β iso-
forms and miR-200 family members, although strong correlations 
were observed with all TGF-β isoforms and ZEBs. These data are con-
sistent with a role for autocrine TGF-β signaling in up-regulating ZEB 
in breast cancer cells, but suggest that there may be differential regu-
lation of the miR-200 family members in this context.
In summary, we have identified a central role for an autocrine 
TGF-β/ZEB/miR-200 signaling network in controlling the transition 
between epithelial and mesenchymal states. Prolonged activation 
of this pathway leads to dynamic epigenetic changes in miR-200 
and may contribute to invasive breast cancer progression. In light of 
these findings, a remarkable connection between EMT and breast 
cancer stem cells was recently demonstrated where TGF-β treat-
ment was shown to initiate EMT and concomitant acquisition of tu-
mor-initiating and self-renewal properties (Mani et al., 2008). Inde-
pendently of these studies, the miR-200 family and ZEB1 have been 
shown to be key regulators of these stem-like properties (Shimono 
et al., 2009; Wellner et al., 2009; Iliopoulos et al., 2010). These ob-
servations provide an intriguing link between the autocrine TGF-β/
ZEB/miR-200 signaling network and the plasticity of EMT and the 
stem-like properties of cells during cancer progression and metasta-
sis (Gupta et al., 2009). Similar links among the TGF-β–related fac-
tors, the bone morphogenetic proteins, and the miR-200 family 
have recently been described in somatic cell reprogramming (Sama-
varchi-Tehrani et al., 2010). It will be of significant interest to exam-
ine the importance of the autocrine TGF-β/ZEB/miR-200 signaling 
network in governing cell plasticity and stemness in developmental 
and pathological scenarios.
MATERIALS AND METHODS
Cell line maintenance and treatments
MDCK cells and their derivatives and human breast cancer cell lines 
were cultured as previously described (Bracken et al., 2008). The 
feedback loop are likely to be driving the initial changes in marker 
expression and cell morphology. Interestingly, the down-regulation 
of the miR-200b∼200a∼429 but not miR-200c∼141 cluster appeared 
to precede detectability of ZEB1 and ZEB2 proteins, suggesting that 
other factors may be responsible for the initial repression of the 
miR-200b∼200a∼429 cluster. These factors might facilitate activation 
of the ZEB/miR-200 feedback loop, which would otherwise be inhib-
ited by high miR-200 levels squelching ZEB translation. The induc-
tion of Snail by TGF-β in MDCK cells has been studied in most detail 
and shown to involve both Smad- and MAPK-dependent pathways 
(Peinado et al., 2003; Medici et al., 2006). Snail and Slug in turn have 
been shown to up-regulate TGF-β3 by a TCF4-β-catenin–dependent 
mechanism (Medici et al., 2008). Our findings are consistent with this 
model in that Snail can induce autocrine TGF-β, but we find that Snail 
remains upstream in this pathway and is not sufficient to maintain the 
mesenchymal state, which requires ongoing ZEB expression.
Our findings in this study with MDCK cells share similarities and 
differences with other EMT cell culture models. In the normal mouse 
mammary epithelial cell NMuMG cell model, prolonged TGF-β1 
stimulation (>2 wk) also induces a full EMT, but, unlike MDCK cells, 
they do not sustain the mesenchymal state long term after TGF-β 
withdrawal (Gal et al., 2008). TGF-β1 treatment has been shown to 
reduce the expression of the miR-200 family in NMuMG cells (Korpal 
et al., 2008); however, we have found that these cells express much 
lower levels of miR-200 than do MDCK cells (unpublished data). 
Therefore, it is feasible that the ZEB/miR-200 feedback loop may 
not play a dominant role in NMuMG cells. In support of this obser-
vation, ZEB1 and ZEB2 induction have been shown to be required 
for TGF-β–mediated repression of E-cadherin but not for induction 
of mesenchymal markers in NMuMG cells (Shirakihara et al., 2007). 
In contrast, we have previously shown that enforced expression of 
miR-200 in MDCK cells prevents up-regulation of ZEB1 and ZEB2 as 
well as changes in epithelial and mesenchymal markers in response 
to TGF-β (Gregory et al., 2008a), confirming that changes in miR-
200 are needed for a complete EMT. Participation of autocrine 
TGF-β signaling in the maintenance of the mesenchymal state has 
been previously observed in MDCK cells where it was found that 
activation of the Ras/Erk/MAPK pathway by stable expression of Raf 
caused cells to undergo a stable EMT associated with the induction 
of autocrine TGF-β signaling (Lehmann et al., 2000). Constitutive 
activation of the MAPK pathway by Ras was also required for TGF-β 
to induce a stable mesenchymal state in mouse mammary EpH4 
cells (Oft et al., 1996; Janda et al., 2002). We did observe an in-
crease in MAPK activity in MDCK-TGF cells; however, inhibition of 
this pathway was not sufficient to revert these cells to an epithelial 
phenotype (unpublished data). It will be interesting to further exam-
ine whether the TGF-β and MAPK pathways converge to regulate 
expression of the ZEB/miR-200 feedback loop.
A major finding of this study is that TGF-β signaling induces re-
versible DNA methylation of the miR-200 promoters. Although it is 
well established that DNA hypermethylation of specific genes oc-
curs in advanced cancers, links between EMT and de novo DNA 
methylation have only recently been described (Dumont et al., 2008; 
Papageorgis et al., 2010). Here we have shown that the miR-200b 
and miR-200c loci are subject to de novo DNA methylation upon 
prolonged TGF-β signaling and that this was reversible upon inhibi-
tion of TGF-β signaling. Changes in the degree of miR-200 pro-
moter methylation closely correlated with miR-200 expression, im-
plicating a role for this process in miR-200 repression. The mechanism 
through which TGF-β signaling controls DNA methylation of miR-
200 is not clear at this stage, but may involve active DNA methyl-
transferases (DNMTs). DNMT activity has been linked with the LSD1 
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et al., 2008a). Nuclei were visualized by costaining with DAPI. Cells 
were visualized on an Olympus IX81 microscope, and pictures were 
taken using a Hamamatsu Orca camera. Images were analyzed with 
Olympus Cell software.
Enzyme-linked immunosorbent assay (ELISA)  
of TGF-β isoforms
Secreted TGF-β1 and TGF-β2 levels were determined using the 
Quantikine human TGF-β1 and -β2 kits (R&D Systems) as per the 
manufacturer’s instruction. Prior to assay, MDCK cells were treated 
with TGF-β1 for 12 d and then grown for a further 6 d without exog-
enous TGF-β1. A stable mesenchymal phenotype was confirmed by 
cell morphology and real-time PCR analysis of epithelial and mesen-
chymal gene expression. Equal numbers of MDCK and MDCK-TGF 
cells were then plated in 12-well trays, grown for 1 d, then grown 
overnight in serum-free medium that was collected for analysis.
Analysis of primary human breast cancer samples
Formalin-fixed, paraffin-embedded (FFPE) deidentified sections 
from invasive ductal breast cancer samples were derived from the 
Breast Biomarker Project at Royal Melbourne Hospital and from the 
Department of Tissue Pathology at SA Pathology. Access to patient 
tumor samples was approved by the appropriate institutional hu-
man ethics review boards. Sections were hematoxylin and eosin 
stained, and regions that contained primarily tumor cells were 
marked for further analysis. Using duplicate unstained sections, 
marked areas of the tumor were scraped into tubes where total RNA 
was isolated using an miRNeasy FFPE kit (Qiagen). cDNA was spe-
cifically primed, then real-time PCR analysis for mRNA was per-
formed using TaqMan assays (Applied Biosystems) and expressed 
relative to GAPDH. Samples were obtained from one to two distinct 
regions from each patient specimen. Each was separately assayed, 
and the triplicate values were averaged and then treated as 
individual data points. Primers for the TaqMan Gene Expression as-
says (with appropriate Applied Biosystems Assay ID) were as fol-
lows: hGAPDH (Hs99999905_m1), hTGF-β1 (Hs00171257_m1), 
hTGF-β2 (Hs01548875_m1), hTGF-β3 (Hs00234245_m1), hZEB1 
(Hs00232783_m1), hZEB2 (Hs00207691_m1). Multiplex miRNA 
cDNA was prepared, then miRNA PCRs were performed using Taq-
Man microRNA assays (Applied Biosystems). Real-time PCR data for 
microRNA are expressed relative to five control miRNAs (U6, miR-
16, miR-24, miR-93, and let-7a). Significance of correlation between 
normalized mRNA and miRNA data was calculated using the 
Pearson correlation.
DNA methylation analysis of the miR-200 loci
Genomic DNA was isolated from cells using TRIzol (Invitrogen). The 
DNA was quantitated on a NanoDrop-1000 (Thermo Fisher Sci-
entific, Scoresby, VIC, Australia), and 500 ng was bisulfite modified 
with the EZ DNA Methylation-Gold Kit according to the manufac-
turer’s protocol (Zymo Research, Irvine, CA). For bisulfite sequenc-
ing, bisulfite-modified DNA was PCR amplified using the bisulfite 
sequencing primers specified in Supplementary Table 2. The size of 
the PCR products was confirmed by electrophoresis on 2% agarose 
gels (Bio-Rad, Hercules, CA) stained with ethidium bromide. The 
PCR products were purified from the agarose gels using the 
QIAquick Gel Extraction Kit (Qiagen). The PCR products were then 
cloned into pGEM-T Easy Vector (Promega, Madison, WI) and se-
lected after transformation into JM109 competent cells (Promega) 
and plating onto LB Agar plates containing 100 μg/ml ampicillin, 0.5 
mM isopropyl-β-d-thiogalactopyranoside, and 80 μg/ml X-Gal. 
White (positive) colonies were selected and cultured overnight, and 
generation of MDCK-EV, MDCK-ZEB1, MDCK-ZEB2, and MDCK-Pez 
stable cell lines has been previously described (Wyatt et al., 2007; 
Bracken et al., 2008). MDCK-Snail cells were made by transfection of 
pcDNA3-mSnail (a gift from Antonio Garcia de Herreros, IMIM-
Hospital del Mar, Barcelona, Spain) and selection of single clones as 
previously described for the ZEB1 and ZEB2 stable cell lines (Bracken 
et al., 2008). TGF-β1, -β2, and -β3 ligands, anti–TGF-β1, -β2, -β3, and 
pan anti–TGF-β1/β2/β3 (R&D Systems, Minneapolis, MN) were used 
at 1 ng/ml or 100 μg/ml, respectively. The TGF-β R1 inhibitors SB-
505124 and SB-431542 (Calbiochem, San Diego, CA) were used at a 
1 μM final concentration. Treatments of MDCK and derivative cell 
lines were commenced 1 d after plating and were readministered at 
time of passage or transfection (∼3–4 d).
Isolation of RNA and real-time PCR
Total RNA was isolated from cell lines, and real-time PCR was per-
formed by using primers as previously described (Gregory et al., 
2008a). Primers for canine TGF-β isoforms and CFL2 are as follows: 
caTGF-β1 (5′-TGGACACGCAGTACAGCAA-3′; 5′-TAGTACACGAT-
GGGCAGTGG-3′), caTGF-β2 (5′-CGTTTACAGAACCCGAAAGC-3′; 
5′-TCGTCTTGACGACTTTGCTG-3′), caTGF-β3 (5′-CTTGCACCAC-
CTTGGACTTT-3′; 5′-CTGTTGTAAAGGGCCAGGAC-3′), and caCFL2 
(5′-ATGGCTTCTGGAGTTACAGTGA-3′; 5’-GCATATCGGCAATCAT-
TCAGAGG-3′). MicroRNA PCRs were performed using TaqMan mi-
croRNA assays (Applied Biosystems, Foster City, CA). Real-time PCR 
data for mRNA and microRNA are expressed relative to glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) or U6, respectively.
Transfection of microRNAs and siRNAs
MDCK and its derivatives were transfected at low density using HiP-
erFect transfection reagent (Qiagen, Chatsworth, CA). For concur-
rent knockdown of ZEB1 and ZEB2, 10 nM of each siRNA (Invitro-
gen; 40 nM total) or a control siRNA was transfected every 3 d for a 
total of 6 d as previously described (Gregory et al., 2008a). Ectopic 
expression of miR-200a and miR-200b (20 nM; Shanghai GenePh-
arma, Shanghai, China) was performed in a similar manner. For 
Smad4 knockdown, 200 nM of siRNA (100 nM each Smad siRNA) or 
control (Shanghai GenePharma) was transfected before the addition 
of TGF-β. The sequences for the canine Smad4 siRNAs are 5′-AGA-
CAGAGCAUCAAAGAAATT-3′ and 5′-UCAGGUGGCUGGUCG-
GAAATT-3′. Inhibition of all members of the miR-200 family was car-
ried out by transfection of a modified LNA Anti-miR with the 
sequence 5′-mU*+C*mG*mU+CmUmU+TmAmC+CmAmG+GmC
mA+GmUmA*+T*mU*mA-3′, where mN is a 2′O-methyl base, + is 
a LNA base, and * is a phosphorothioate bond. Anti-miR transfec-
tions were performed as mentioned earlier in the text for 10–14 d 
using a 300 nM final concentration.
Western blotting and immunofluorescence
Western blotting was performed as previously described (Gregory 
et al., 2008a). The following primary antibodies were used: ZEB1 
(1:2000 vol:vol, A301–922A, Bethyl Laboratories, Montgomery, TX), 
ZEB2 (1:5000 vol:vol; Christoffersen et al., 2007), E-cadherin (1:1000 
vol:vol, 610182; BD Transduction Laboratories), and tubulin (1:5000 
vol:vol, ab7291; Abcam, Cambridge, MA). Membranes were ex-
posed using enhanced chemiluminescence (GE Healthcare, 
Buckinghamshire, UK) and imaged using the LAS4000 Luminescent 
Image Analyzer (Fujifilm, Tokyo, Japan). For immunofluorescence, 
cells were plated on fibronectin-coated chamber slides (Nunc, 
Rochester, NY) and stained using anti-E-cadherin (1:500 vol:vol, as 
mentioned earlier in the text), ZO-1 (1:500 vol:vol; Zymed, South 
San Francisco, CA), or F-actin as previously described (Gregory 
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